Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate

Summary

The primary objective of this study is to evaluate the efficacy (ACR20) of Rob 803 administered orally once daily for 12 weeks in combination with a stable dose of methotrexate in subjects with moderate or severe active RA.

Timeline

Start

2007-10

Primary completion

2009-08

Completion

2009-08

Drugs

Indications